annb0t
Top 20
We feel now is a pretty good time to analyse Mesoblast Limited's (ASX:MSB) business as it appears the company may be on the cusp of a considerable accomplishment. Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, the United Kingdom, and Switzerland. With the latest financial year loss of US$91m and a trailing-twelve-month loss of US$86m, the AU$814m market-cap company alleviated its loss by moving closer towards its target ...
>>> Read more: Mesoblast Limited's (ASX:MSB) Shift From Loss To Profit
>>> Read more: Mesoblast Limited's (ASX:MSB) Shift From Loss To Profit
